North America Epirubicin Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Epirubicin Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Epirubicin Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Epirubicin Market Regional Analysis

6.2 North America Epirubicin Market Revenue 2020-2028 (US$ Thousand)

6.3 North America Epirubicin Market Forecast Analysis

7. North America Epirubicin Market Analysis – by Dosage

7.1 10mg/Vial

7.1.1 Overview
7.1.2 10mg/Vial: North America Epirubicin Market – Revenue and Forecast, 2020-2028 (US$ Thousand)

7.2 50mg/Vial

7.2.1 Overview
7.2.2 50mg/Vial: North America Epirubicin Market – Revenue and Forecast, 2020-2028 (US$ Thousand)

7.3 100mg/Vial

7.3.1 Overview
7.3.2 100mg/Vial: North America Epirubicin Market – Revenue and Forecast, 2020-2028 (US$ Thousand)

7.4 200mg/Vial

7.4.1 Overview
7.4.2 200mg/Vial: North America Epirubicin Market – Revenue and Forecast, 2020-2028 (US$ Thousand)

8. North America Epirubicin Market Analysis – by Application

8.1 Breast Cancer

8.1.1 Overview
8.1.2 Breast Cancer: North America Epirubicin Market – Revenue and Forecast, 2020-2028 (US$ Thousand)

8.2 Liver Cancer

8.2.1 Overview
8.2.2 Liver Cancer: North America Epirubicin Market – Revenue and Forecast, 2020-2028 (US$ Thousand)

8.3 Bladder Cancer

8.3.1 Overview
8.3.2 Bladder Cancer: North America Epirubicin Market – Revenue and Forecast, 2020-2028 (US$ Thousand)

9. North America Epirubicin Market Analysis – by Distribution Channel

9.1 Hospital Pharmacies

9.1.1 Overview
9.1.2 Hospital Pharmacies: North America Epirubicin Market – Revenue and Forecast, 2020-2028 (US$ Thousand)

9.2 Retail Pharmacies

9.2.1 Overview
9.2.2 Retail Pharmacies: North America Epirubicin Market – Revenue and Forecast, 2020-2028 (US$ Thousand)

9.3 Online Pharmacies

9.3.1 Overview
9.3.2 Online Pharmacies : North America Epirubicin Market – Revenue and Forecast, 2020-2028 (US$ Thousand)

10. North America Epirubicin Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Epirubicin Market Breakdown, by Key Country, 2023 and 2028 (%)
10.2.1.1 North America Epirubicin Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)

10.2.1.1.1 US: North America Epirubicin Market Breakdown, by Dosage
10.2.1.1.2 US: North America Epirubicin Market Breakdown, by Application
10.2.1.1.3 US: North America Epirubicin Market Breakdown, by Distribution Channel

10.2.1.2 Canada: North America Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)

10.2.1.2.1 Canada: North America Epirubicin Market Breakdown, by Dosage
10.2.1.2.2 Canada: North America Epirubicin Market Breakdown, by Application
10.2.1.2.3 Canada: North America Epirubicin Market Breakdown, by Distribution Channel

10.2.1.3 Mexico : North America Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)

10.2.1.3.1 Mexico : North America Epirubicin Market Breakdown, by Dosage
10.2.1.3.2 Mexico : North America Epirubicin Market Breakdown, by Application
10.2.1.3.3 Mexico : North America Epirubicin Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Areva Pharmaceuticals

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Fresenius Kabi AG

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Hikma Pharmaceuticals PLC

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Mylan N.V.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Pfizer Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Salius Pharma Pvt Ltd

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Teva Pharmaceutical Industries Ltd.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Epirubicin Market

Analysis – by Dosage (10mg/Vial, 50mg/Vial, 100mg/Vial, and 200mg/Vial), Application (Breast Cancer, Liver Cancer, Bladder Cancer, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)